Unrecognized Tax Benefits of Coherus Oncology, Inc. from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Coherus Oncology, Inc. quarterly Unrecognized Tax Benefits in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • Coherus Oncology, Inc. Unrecognized Tax Benefits for the quarter ending 31 Dec 2025 was $20,017,000, a 4% increase year-over-year.
Source SEC data
View on sec.gov
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Change (%)

Coherus Oncology, Inc. Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $20,017,000 +$770,000 +4% 31 Dec 2025 10-K 09 Mar 2026 2025 FY
Q4 2024 $19,247,000 +$1,830,000 +11% 31 Dec 2024 10-K 09 Mar 2026 2025 FY
Q4 2023 $17,417,000 +$579,000 +3.4% 31 Dec 2023 10-K 09 Mar 2026 2025 FY
Q4 2022 $16,838,000 +$1,343,000 +8.7% 31 Dec 2022 8-K 13 Nov 2025
Q4 2021 $15,495,000 +$2,252,000 +17% 31 Dec 2021 10-K 17 Mar 2025 2024 FY
Q4 2020 $13,243,000 +$1,640,000 +14% 31 Dec 2020 10-K 15 Mar 2024 2023 FY
Q4 2019 $11,603,000 -$6,512,000 -36% 31 Dec 2019 10-K 06 Mar 2023 2022 FY
Q4 2018 $18,115,000 +$2,433,000 +16% 31 Dec 2018 10-K 23 Feb 2022 2021 FY
Q4 2017 $15,682,000 -$3,000,000 -16% 31 Dec 2017 10-K 25 Feb 2021 2020 FY
Q4 2016 $18,682,000 +$8,077,000 +76% 31 Dec 2016 10-K 27 Feb 2020 2019 FY
Q4 2015 $10,605,000 +$6,789,000 +178% 31 Dec 2015 10-K 28 Feb 2019 2018 FY
Q4 2014 $3,816,000 +$3,067,000 +409% 31 Dec 2014 10-K 08 Mar 2018 2017 FY
Q4 2013 $749,000 +$676,000 +926% 31 Dec 2013 10-K 14 Mar 2017 2016 FY
Q4 2012 $73,000 -$13,927,000 -99% 31 Dec 2012 10-K 29 Feb 2016 2015 FY
Q4 2011 $14,000,000 31 Dec 2011 10-K 23 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.